Skip to main content
. 2023 Apr 24;6(5):820–828. doi: 10.1021/acsptsci.3c00038

Figure 2.

Figure 2

Representative pathological image of a patient with LSCC diagnosis showing invasiveness, heterogeneity, and amorphous cell formation (100 μm hematoxylin and eosin staining; by ImageScope). Red arrow: infiltrative cancer cells.